消渴Ⅱ号方对早期糖尿病肾病患者免疫功能的影响  被引量:1

Effect of Xiaoke Ⅱ Prescription on Immune Function in Patients with Early Diabetic Nephropathy

在线阅读下载全文

作  者:张素英 田伟伟 刘光义 丁翠欣 李瑞杰 李瑞静 赵晶晶 ZHANG Suying;TIAN Weiwei;LIU Guangyi;DING Cuixin;LI Ruijie;LI Ruijing;ZHAO Jingjing(Department of Internal Medicine,Xinle Hospital of Traditional Chinese Medicine,Hebei Province,Xinle 050700,China)

机构地区:[1]新乐市中医医院内一科

出  处:《中国中医药现代远程教育》2019年第19期82-84,共3页Chinese Medicine Modern Distance Education of China

基  金:河北省中医药管理局科研计划项目【No.2018298】

摘  要:目的探讨自拟消渴Ⅱ号方对早期糖尿病肾病患者免疫功能的影响。方法选择60例2型糖尿病肾病患者,Mogensen分期为糖尿病肾病早期,随机分为治疗组和对照组,对照组28例,治疗组32例,2组均予二甲双胍或拜糖平或(和)胰岛素治疗。对照组在基础治疗的基础上加用厄贝沙坦口服,每日1次,每次1片;治疗组在对照组治疗的基础上加用自拟消渴Ⅱ号方汤剂。治疗前后观察2组证候疗效、空腹血糖、尿白蛋白排泄率及免疫功能。结果2组治疗后总有效率比较差异有统计学意义(P<0.01)。治疗组能明显改善患者临床症状,改善CD^4+、CD^8+、CD^4+/CD^8+水平。结论自拟消渴Ⅱ号方能提高早期糖尿病肾病治疗疗效,增强患者免疫力,有效改善临床症状。Objective To investigate the effect of self-formulated Xiaoke II on immune function of early diabetic nephropathy patients.Methods 60 patients with type 2 diabetic nephropathy were selected.Mogensen was divided into the early stage of diabetic nephropathy.Patients were randomly divided into the treatment group and the control group,with 28 cases in the control group and 32 cases in the treatment group.Both groups were given Metformin or glycoside and/or insulin therapy.The control group added Ebeishatan(trade name:Anbowei,specification 150 mg/tablet,Sanofi(Hangzhou)Pharmaceutical Co.,Ltd.)on the basis of basic treatment,oral,once a day,1 tablet each time.On the basis of the control group's treatment,the treatment group added a self-prepared Xiaoke II prescription,which was fried with one dose of water per day,divided into 2 oral sessions and 12 treatment sessions on Monday.Results There were significant differences in total efficiency before and after treatment between the two groups(P<0.01).The treatment group can significantly improve the patient's clinical symptoms and improve the levels of CD^4+,CD^8+,and CD^4+/CD^8+.Conclusion Self-formulated Xiaoke II prescription can improve the curative effect of early diabetic nephropathy,enhance the immunity of patients,and effectively improve clinical symptoms.

关 键 词:消渴Ⅱ号方 糖尿病 肾病 临床证候 免疫功能 消渴 水肿 

分 类 号:R58[医药卫生—内分泌]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象